The company’s US operation, which is currently unprofitable, is projected to turn around within the next two to three years.

Brokerages Motilal Oswal and Jefferies have maintained positive outlooks for ICICI Bank, Torrent Pharmaceuticals, and Godrej ...

Also, they introduced 25 new products during the year.Torrent Pharmas presence in Germany started with the acquisition of Heumann Pharma from Pfizer in 2004-05. The Company entered into a License ...

Cipla, Aurobindo, Lupin, Torrent Pharma and others have found resolutions ... latest quarters indicating a return to normalcy. Complex product traction has been the main driver.

Torrent Pharma reported a 14% YoY rise in Q3FY25 net profit to ₹503 crore, driven by strong India sales growth of 12% and revenue momentum in Germany.

Novartis Pharmaceuticals Corporation v. Torrent Pharma Inc., No. 23-2218 (Fed. Cir. 2025) — On January 10, 2025, the Federal Circuit reversed ...

For example, in 2015 Novartis lost a patent fight with Torrent Pharmaceuticals over ... little opportunity for patent protection for pharma products. While the countries that joined the World ...

Products and services Sun Pharma is one ... Pharmaceuticals Industries Ltd are Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd ...

Stocks like Balkrishna Industries, JK Cement, IDFC First Bank, Macrotech Developers, Trident, NTPC Green Energy, CreditAccess ...